login
login

Europe Daily Bulletin No. 7886

22 January 2001
Contents Publication in full By article 41 / 47
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

In Belgium, the biotechnology companies VIRCO and TIBOTEC are considering merging, creating a new entity which will concentrate the parties activities and which will be specialised in the treatment of AIDS, infectious diseases and oncology. It will be 65% held by TIBOTEC and 35% by VIRCO.

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION
WEEKLY SUPPLEMENT